R&D Partner Content Returning for a 4th Year... GPCRs-Targeted Drug Discovery! Transforming the Discovery of Novel GPCR-Targeted Therapies
R&D Partner Content 2nd ESG in Life Sciences Summit Europe Mastering Life Science ESG Compliance & Strategic Impact in 2025
R&D Partner Content 6th GxP Cloud Compliance Summit 2025 Advancing AI Advancing AI Validation, Risk Management, and Cloud Security to Ensure GxP Cloud Compliance
R&D Partner Content Innovation in Psychosis Therapeutics Summit Join leaders at the Innovation in Psychosis Therapeutics Summit to revolutionize psychosis treatment
R&D Partner Content 4th ALS Drug Development Summit Join 200+ experts at the 4th ALS Summit to advance biomarkers, targets, and trials for ALS & FTD
News Outlook blindsided as FDA blocks wet AMD drug once again Shares in Outlook Therapeutics lost more than half their value after the FDA turned down the company's marketing application for its wet AMD therapy.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
